- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04950816
Examining the Feasibility and Acceptability of a Tailored Version of a Mindfulness-Based Intervention (MBI) Among Youth Experiencing Homelessness (YEH)
August 7, 2025 updated by: Diane Santa Maria, The University of Texas Health Science Center, Houston
Examining the Feasibility and Acceptability of a Tailored Version of a Mindfulness-Based Intervention (MBI) Among Youth Experiencing Homelessness (YEH) Aged 18-25 Years Old
The purpose of this study is to conduct a trial of the tailored Mindfulness- Based Intervention (MBI) (.b) vs. attention control to test real-world feasibility and acceptability of this tailored Mindfulness - Based Intervention (MBI) in youth experiencing homelessness (YEH).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
90
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77030
- The University of Texas Health Science Center at Houston
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 25 years (Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- homeless youth receiving services at one of the recruitment sites in Houston, Texas area at the time of enrollment
- English speaking
- able to participate for the entire study period (i.e., not moving during the study)
Exclusion Criteria:
- overtly exhibiting symptoms of severe, untreated mental illness criteria
- not staying at the shelter
- currently experiencing homelessness or unstable housing
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: tailored MBI (.b)
|
The session will include brief didactic presentations, videos, and mindfulness practice followed by inquiry.
We anticipate that sessions will take place twice a week.
Sessions will be held on site at the Covenant House Texas (CHT) shelter in a quiet, designated learning space to ease access to sessions for the participants and to assure access to shelter staff (e.g., social workers and case managers) and services (e.g., food and shelter).
CHT has onsite, weekday clinical and mental health care and established protocols for accessing needed resources 24/7.
Selection criteria for the interventionist include maintaining a personal mindfulness practice for at least two years, trained in .b,
and prior experience working with high-risk youth.
The interventionist will receive additional training in Trauma-Informed Care as well as study procedures.
|
|
Active Comparator: attention control condition
|
Participants will receive no training in MBI or meditation.
Topics covered may include physical activity, nutrition, managing weight, understanding adolescence, personal care, avoiding tobacco, alcohol, and drugs though this will be finalized in YR-1 with the HYWG and advisory panel.
The HT program will be led by a positive adult instructor with training in health education or a related field and experience working with YEH.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Emotion Regulation as Measured by Difficulties in Emotion Regulation Scale (DERS)
Time Frame: Baseline
|
The DERS is a 36-item questionnaire, and each item is scored from 1(almost never)-5 (almost always).
The 36 items were added to generate a scale from 36 to 180, a higher score indicates greater problem with emotion regulation.
|
Baseline
|
|
Emotion Regulation as Measured by Difficulties in Emotion Regulation Scale (DERS)
Time Frame: immediately after completing the intervention (about 2 to 4 weeks after baseline)
|
The DERS is a 36-item questionnaire, and each item is scored from 1(almost never)-5 (almost always).
The 36 items were added to generate a scale from 36 to 180, a higher score indicates greater problem with emotion regulation.
|
immediately after completing the intervention (about 2 to 4 weeks after baseline)
|
|
Emotion Regulation as Measured by Difficulties in Emotion Regulation Scale (DERS)
Time Frame: 3 months post intervention
|
The DERS is a 36-item questionnaire, and each item is scored from 1(almost never)-5 (almost always).
The 36 items were added to generate a scale from 36 to 180, a higher score indicates greater problem with emotion regulation.
|
3 months post intervention
|
|
Emotion Regulation as Measured by Difficulties in Emotion Regulation Scale (DERS)
Time Frame: 6 months post intervention
|
The DERS is a 36-item questionnaire, and each item is scored from 1(almost never)-5 (almost always).
The 36 items were added to generate a scale from 36 to 180, a higher score indicates greater problem with emotion regulation.
|
6 months post intervention
|
|
Mindfulness as Measured by Child and Adolescent Mindfulness Measure (CAMM)
Time Frame: Baseline
|
The CAMM is a 10 item questionnaire and each item is scored from 0(never true)-4 (always true).
The 10 items were added to generate a scale from 0 to 40, a higher score indicates higher levels of mindfulness
|
Baseline
|
|
Mindfulness as Measured by Child and Adolescent Mindfulness Measure (CAMM)
Time Frame: immediately after completing the intervention (about 2 to 4 weeks after baseline)
|
The CAMM is a 10 item questionnaire and each item is scored from 0(never true)-4 (always true).
The 10 items were added to generate a scale from 0 to 40, a higher score indicates higher levels of mindfulness
|
immediately after completing the intervention (about 2 to 4 weeks after baseline)
|
|
Mindfulness as Measured by Child and Adolescent Mindfulness Measure (CAMM)
Time Frame: 3 months post intervention
|
The CAMM is a 10 item questionnaire and each item is scored from 0(never true)-4 (always true).
The 10 items were added to generate a scale from 0 to 40, a higher score indicates higher levels of mindfulness
|
3 months post intervention
|
|
Mindfulness as Measured by Child and Adolescent Mindfulness Measure (CAMM)
Time Frame: 6 months post intervention
|
The CAMM is a 10 item questionnaire and each item is scored from 0(never true)-4 (always true).
The 10 items were added to generate a scale from 0 to 40, a higher score indicates higher levels of mindfulness
|
6 months post intervention
|
|
Mindfulness as Measured by Cognitive and Affective Mindfulness Scale-Revised (CAMS-R)
Time Frame: Baseline, immediately after intervention (about 2 to 4 weeks after baseline),3 months post intervention,6 months post intervention
|
The CAMS-R is a 12-item measure and each item is scored from 1( rarely/not at all)-4(almost always).
Higher values reflect greater mindful qualities
|
Baseline, immediately after intervention (about 2 to 4 weeks after baseline),3 months post intervention,6 months post intervention
|
|
Self-Compassion as Measured by Self-Compassion Scale (SCS)
Time Frame: Baseline
|
The Self-Compassion Scale (SCS) total score ranges from 1 to 5, higher score indicating greater self compassion..
|
Baseline
|
|
Self-Compassion as Measured by Self-Compassion Scale (SCS)
Time Frame: immediately after completing the intervention (about 2 to 4 weeks after baseline)
|
The Self-Compassion Scale (SCS) total score ranges from 1 to 5, higher score indicating greater self compassion.
|
immediately after completing the intervention (about 2 to 4 weeks after baseline)
|
|
Self-Compassion as Measured by Self-Compassion Scale (SCS)
Time Frame: 3 months post intervention
|
The Self-Compassion Scale (SCS) total score ranges from 1 to 5, higher score indicating greater self compassion.
|
3 months post intervention
|
|
Self-Compassion as Measured by Self-Compassion Scale (SCS)
Time Frame: 6 months post intervention
|
The Self-Compassion Scale (SCS) total score ranges from 1 to 5, higher score indicating greater self compassion.
|
6 months post intervention
|
|
Stress as Measured by Perceived Stress Scale (PSS)
Time Frame: Baseline
|
The PSS is a 10 item questionnaire and each item is scored from 0(never)-4(very often).
The 10 items were added to generate a scale from 0 to 40, higher score indicating a higher perceived stress.
|
Baseline
|
|
Stress as Measured by Perceived Stress Scale (PSS)
Time Frame: immediately after completing the intervention (about 2 to 4 weeks after baseline)
|
The PSS is a 10 item questionnaire and each item is scored from 0(never)-4(very often).
The 10 items were added to generate a scale from 0 to 40, higher score indicating a higher perceived stress.
|
immediately after completing the intervention (about 2 to 4 weeks after baseline)
|
|
Stress as Measured by Perceived Stress Scale (PSS)
Time Frame: 3 months post intervention
|
The PSS is a 10 item questionnaire and each item is scored from 0(never)-4(very often).
The 10 items were added to generate a scale from 0 to 40, higher score indicating a higher perceived stress.
|
3 months post intervention
|
|
Stress as Measured by Perceived Stress Scale (PSS)
Time Frame: 6 months post intervention
|
The PSS is a 10 item questionnaire and each item is scored from 0(never)-4(very often).
The 10 items were added to generate a scale from 0 to 40, higher score indicating a higher perceived stress.
|
6 months post intervention
|
|
Feasibility as Assessed by the Percentage of Participants Enrolled in the Study
Time Frame: Baseline
|
Percentage of participants who met study eligibility criteria who enroll (provide informed consent) in the study
|
Baseline
|
|
Feasibility as Assessed by the Number of Participants Who Adhere to Treatment
Time Frame: 6 months post intervention
|
Number of participants who adhere to treatment is measured by the number of participants who attended at least 3 of 5 group sessions.
|
6 months post intervention
|
|
Feasibility as Assessed by the Number of Participants Who Completed the 3 Months Follow up
Time Frame: 3 months post intervention
|
3 months post intervention
|
|
|
Feasibility as Assessed by the Number of Participants Who Completed the 6 Months Follow up
Time Frame: 6 months post intervention
|
6 months post intervention
|
|
|
Acceptability as Assessed by the Credibility and Expectancy Questionnaire - Expectancy Subscale
Time Frame: 6 months post intervention
|
The Credibility and Expectancy Questionnaire (CEQ) was used to assess the acceptability of the intervention.
All participants completed both subscales: the credibility subscale and the expectancy subscale.
Each subscale total score ranges from 0 to 10, with higher scores indicating greater perceived acceptability.
The expectancy subscale is reported.
|
6 months post intervention
|
|
Acceptability as Assessed by the Credibility and Expectancy Questionnaire - Credibility Subscale
Time Frame: 6 months post intervention
|
The Credibility and Expectancy Questionnaire (CEQ) was used to assess the acceptability of the intervention.
All participants completed both subscales: the credibility subscale and the expectancy subscale.
Each subscale total score ranges from 0 to 10, with higher scores indicating greater perceived acceptability.
The credibility subscale is reported.
|
6 months post intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Social Connectedness as Measured Social Connectedness Scale
Time Frame: Baseline
|
The scale is a 8 item questionnaire and each item is scored from 1(strongly disagree)-6(strongly agree).
The 8 items were added to generate a scale from, 8 to 48, a higher score indicating more connectedness to others.
|
Baseline
|
|
Social Connectedness as Measured Social Connectedness Scale
Time Frame: immediately after completing the intervention (about 2 to 4 weeks after baseline)
|
The scale is a 8 item questionnaire and each item is scored from 1(strongly disagree)-6(strongly agree).
The 8 items were added to generate a scale from, 8 to 48, a higher score indicating more connectedness to others.
|
immediately after completing the intervention (about 2 to 4 weeks after baseline)
|
|
Social Connectedness as Measured Social Connectedness Scale
Time Frame: 3 months post intervention
|
The scale is a 8 item questionnaire and each item is scored from 1(strongly disagree)-6(strongly agree).
The 8 items were added to generate a scale from, 8 to 48, a higher score indicating more connectedness to others.
|
3 months post intervention
|
|
Social Connectedness as Measured Social Connectedness Scale
Time Frame: 6 months post intervention
|
The scale is a 8 item questionnaire and each item is scored from 1(strongly disagree)-6(strongly agree).
The 8 items were added to generate a scale from, 8 to 48, a higher score indicating more connectedness to others.
|
6 months post intervention
|
|
Depression as Measured by Short Mood and Feelings Questionnaire (SMFQ)
Time Frame: Baseline, immediately after intervention (1day after baseline),3 months post intervention,6 months post intervention
|
The scale is a 13 item questionnaire and each item is scored from 0(not true)-2(true),higher score indicating worse outcome
|
Baseline, immediately after intervention (1day after baseline),3 months post intervention,6 months post intervention
|
|
Anxiety as Measured by Spielberger State-Trait Anxiety Inventory
Time Frame: Baseline, immediately after intervention (1day after baseline),3 months post intervention,6 months post intervention
|
This scale is a 40 item questionnaire, each question is scored from 1(very much so)-4 (not at all), a higher score indicates a worse outcome
|
Baseline, immediately after intervention (1day after baseline),3 months post intervention,6 months post intervention
|
|
Vulnerability as Measured by Psychological Vulnerability Scale
Time Frame: Baseline
|
The Psychological Vulnerability Scale is a 6 item questionnaire.
Each item is scored from 1 (does not describe me at all) to 5 (describes me very well).
The 6 items were added to generate a scale from 6 to 30, a higher score indicates more vulnerability.
|
Baseline
|
|
Vulnerability as Measured by Psychological Vulnerability Scale
Time Frame: immediately after completing the intervention (about 2 to 4 weeks after baseline)
|
The Psychological Vulnerability Scale is a 6 item questionnaire.
Each item is scored from 1 (does not describe me at all) to 5 (describes me very well).
The 6 items were added to generate a scale from 6 to 30, a higher score indicates more vulnerability.
|
immediately after completing the intervention (about 2 to 4 weeks after baseline)
|
|
Vulnerability as Measured by Psychological Vulnerability Scale
Time Frame: 3 months post intervention
|
The Psychological Vulnerability Scale is a 6 item questionnaire.
Each item is scored from 1 (does not describe me at all) to 5 (describes me very well).
The 6 items were added to generate a scale from 6 to 30, a higher score indicates more vulnerability.
|
3 months post intervention
|
|
Vulnerability as Measured by Psychological Vulnerability Scale
Time Frame: 6 months post intervention
|
The Psychological Vulnerability Scale is a 6 item questionnaire.
Each item is scored from 1 (does not describe me at all) to 5 (describes me very well).
The 6 items were added to generate a scale from 6 to 30, a higher score indicates more vulnerability.
|
6 months post intervention
|
|
Risk Seeking as Measured by Balloon Analogue Risk Task (BART)
Time Frame: Baseline, immediately after intervention (about 2-4 weeks after baseline),3 months post intervention,6 months post intervention
|
The Balloon Analogue Risk Task (BART) is a computerized measure of risk taking behavior.
Each click causes the balloon to incrementally inflate and money to be added to a counter up until some threshold, at which point the balloon is over inflated and explodes.
The primary score used to measure BART performance is the adjusted average number of pumps on unexploded balloons, with higher scores indicative of greater risk-taking propensity
|
Baseline, immediately after intervention (about 2-4 weeks after baseline),3 months post intervention,6 months post intervention
|
|
Distress as Measured by Kessler Psychological Distress Scale (K10)
Time Frame: Baseline, immediately after intervention (1day after baseline),3 months post intervention,6 months post intervention
|
This is a 10-item questionnaire,each item is scored from 1(none of the time)-5(all of the time) for a total score ranging from 10-50 and a higher score indicating worse outcome
|
Baseline, immediately after intervention (1day after baseline),3 months post intervention,6 months post intervention
|
|
Number of Participants Who Are Sexually Active
Time Frame: Baseline
|
A single item question was used to assess this outcome.
The item asked whether or not you ever had sexual intercourse.
The number of participants who answered yes is reported.
|
Baseline
|
|
Number of Participants Who Are Sexually Active
Time Frame: immediately after completing the intervention (about 2 to 4 weeks after baseline)
|
A single item question was used to assess this outcome.
The item asked whether or not you ever had sexual intercourse.
The number of participants who answered yes is reported.
|
immediately after completing the intervention (about 2 to 4 weeks after baseline)
|
|
Number of Participants Who Are Sexually Active
Time Frame: 3 months post intervention
|
A single item question was used to assess this outcome.
The item asked whether or not you ever had sexual intercourse.
The number of participants who answered yes is reported.
|
3 months post intervention
|
|
Number of Participants Who Are Sexually Active
Time Frame: 6 months post intervention
|
A single item question was used to assess this outcome.
The item asked whether or not you ever had sexual intercourse.
The number of participants who answered yes is reported.
|
6 months post intervention
|
|
Number of Participants Who Ever Used Drugs or Substances (Marijuana, Prescription Pain Medicine Without a Prescription, Synethic Marijuana, Cocaine, Inhalants, Heroin, Meth, Ecstasy, Injection Drugs)
Time Frame: Baseline
|
A single item question was used to assess this outcome.
The item listed various drug substances and asked whether any of those listed had been used in their life.
The number of participants who answered yes is reported.
|
Baseline
|
|
Number of Participants Who Ever Used Drugs or Substances (Marijuana, Prescription Pain Medicine Without a Prescription, Synethic Marijuana, Cocaine, Inhalants, Heroin, Meth, Ecstasy, Injection Drugs)
Time Frame: Immediately after completing the intervention (about 2 to 4 weeks after baseline)
|
A single item question was used to assess this outcome.
The item listed various drug substances and asked whether any of those listed had been used in their life.
The number of participants who answered yes is reported.
|
Immediately after completing the intervention (about 2 to 4 weeks after baseline)
|
|
Number of Participants Who Ever Used Drugs or Substances (Marijuana, Prescription Pain Medicine Without a Prescription, Synethic Marijuana, Cocaine, Inhalants, Heroin, Meth, Ecstasy, Injection Drugs)
Time Frame: 3 months post intervention
|
A single item question was used to assess this outcome.
The item listed various drug substances and asked whether any of those listed had been used in their life.
The number of participants who answered yes is reported.
|
3 months post intervention
|
|
Number of Participants Who Ever Used Drugs or Substances (Marijuana, Prescription Pain Medicine Without a Prescription, Synethic Marijuana, Cocaine, Inhalants, Heroin, Meth, Ecstasy, Injection Drugs)
Time Frame: 6 months post intervention
|
A single item question was used to assess this outcome.
The item listed various drug substances and asked whether any of those listed had been used in their life.
The number of participants who answered yes is reported.
|
6 months post intervention
|
|
Depression as Measured by Patient Health Questionnaire-9 (PHQ-9)
Time Frame: Baseline
|
The Patient Health Questionnaire (PHQ-9) is a 9 item questionnaire.
Each Item is scored from 0 (not at all) to 3 (nearly every day).
The 9 items were added to generate a scale from 0 to 27, with higher scores indicating more severe depression.
|
Baseline
|
|
Depression as Measured by Patient Health Questionnaire-9 (PHQ-9)
Time Frame: immediately after completing the intervention (about 2 to 4 weeks after baseline)
|
The Patient Health Questionnaire (PHQ-9) is a 9 item questionnaire.
Each Item is scored from 0 (not at all) to 3 (nearly every day).
The 9 items were added to generate a scale from 0 to 27, with higher scores indicating more severe depression.
|
immediately after completing the intervention (about 2 to 4 weeks after baseline)
|
|
Depression as Measured by Patient Health Questionnaire-9 (PHQ-9)
Time Frame: 3 months post intervention
|
The Patient Health Questionnaire (PHQ-9) is a 9 item questionnaire.
Each Item is scored from 0 (not at all) to 3 (nearly every day).
The 9 items were added to generate a scale from 0 to 27, with higher scores indicating more severe depression.
|
3 months post intervention
|
|
Depression as Measured by Patient Health Questionnaire-9 (PHQ-9)
Time Frame: 6 months post intervention
|
The Patient Health Questionnaire (PHQ-9) is a 9 item questionnaire.
Each Item is scored from 0 (not at all) to 3 (nearly every day).
The 9 items were added to generate a scale from 0 to 27, with higher scores indicating more severe depression.
|
6 months post intervention
|
|
Anxiety as Measured by Generalized Anxiety Disorder (GAD) Scale
Time Frame: Baseline
|
The Anxiety as Measured by Generalized Anxiety Disorder (GAD) scale is a 7 item questionnaire.
Each item is scored from 0 (not at all) to 3 (nearly every day).
The 7 items were added to generate a scale from 0 to 21, with higher scores indicating greater severity of symptoms of anxiety.
|
Baseline
|
|
Anxiety as Measured by Generalized Anxiety Disorder (GAD) Scale
Time Frame: immediately after completing the intervention (about 2 to 4 weeks after baseline)
|
The Anxiety as Measured by Generalized Anxiety Disorder (GAD) scale is a 7 item questionnaire.
Each item is scored from 0 (not at all) to 3 (nearly every day).
The 7 items were added to generate a scale from 0 to 21, with higher scores indicating greater severity of symptoms of anxiety.
|
immediately after completing the intervention (about 2 to 4 weeks after baseline)
|
|
Anxiety as Measured by Generalized Anxiety Disorder (GAD) Scale
Time Frame: 3 months post intervention
|
The Anxiety as Measured by Generalized Anxiety Disorder (GAD) scale is a 7 item questionnaire.
Each item is scored from 0 (not at all) to 3 (nearly every day).
The 7 items were added to generate a scale from 0 to 21, with higher scores indicating greater severity of symptoms of anxiety.
|
3 months post intervention
|
|
Anxiety as Measured by Generalized Anxiety Disorder (GAD) Scale
Time Frame: 6 months post intervention
|
The Anxiety as Measured by Generalized Anxiety Disorder (GAD) scale is a 7 item questionnaire.
Each item is scored from 0 (not at all) to 3 (nearly every day).
The 7 items were added to generate a scale from 0 to 21, with higher scores indicating greater severity of symptoms of anxiety.
|
6 months post intervention
|
|
Distress as Measured by PROMIS Item Bank v.1.0-Emotional Distress
Time Frame: Baseline
|
The Promise item bank v.1.0-
Emotional Distress 7 item questionnaire includes responses from 1 (never) to 5 (always).
Total score ranges from 7 to 35, a higher score indicating higher emotional distress.
|
Baseline
|
|
Distress as Measured by PROMIS Item Bank v.1.0-Emotional Distress
Time Frame: immediately after completing the intervention (about 2 to 4 weeks after baseline)
|
The Promise item bank v.1.0-
Emotional Distress 7 item questionnaire includes responses from 1 (never) to 5 (always).
Total score ranges from 7 to 35, a higher score indicating higher emotional distress.
|
immediately after completing the intervention (about 2 to 4 weeks after baseline)
|
|
Distress as Measured by PROMIS Item Bank v.1.0-Emotional Distress
Time Frame: 3 months post intervention
|
The Promise item bank v.1.0-
Emotional Distress 7 item questionnaire includes responses from 1 (never) to 5 (always).
Total score ranges from 7 to 35, a higher score indicating higher emotional distress.
|
3 months post intervention
|
|
Distress as Measured by PROMIS Item Bank v.1.0-Emotional Distress
Time Frame: 6 months post intervention
|
The Promise item bank v.1.0-
Emotional Distress 7 item questionnaire includes responses from 1 (never) to 5 (always).
Total score ranges from 7 to 35, a higher score indicating higher emotional distress.
|
6 months post intervention
|
|
Risk Seeking as Measured by Risk Propensity Scale.
Time Frame: Baseline
|
The Risk Propensity Scale is 7 items and total score ranges from 0 to 100, a higher score indicating greater risk taking.
|
Baseline
|
|
Risk Seeking as Measured by Risk Propensity Scale.
Time Frame: immediately after completing the intervention (about 2 to 4 weeks after baseline)
|
The Risk Propensity Scale is 7 items and total score ranges from 0 to 100, a higher score indicating greater risk taking.
|
immediately after completing the intervention (about 2 to 4 weeks after baseline)
|
|
Risk Seeking as Measured by Risk Propensity Scale.
Time Frame: 3 months post intervention
|
The Risk Propensity Scale is 7 items and total score ranges from 0 to 100, a higher score indicating greater risk taking.
|
3 months post intervention
|
|
Risk Seeking as Measured by Risk Propensity Scale.
Time Frame: 6 months post intervention
|
The Risk Propensity Scale is 7 items and total score ranges from 0 to 100, a higher score indicating greater risk taking.
|
6 months post intervention
|
|
Executive Function as Measured by the Amsterdam Executive Function Inventory (AEFI)
Time Frame: Baseline
|
Executive Function as Measured by the 13 item Amsterdam Executive Function Inventory (AEFI) total score ranges from 1 (true) to 3 (not true), higher score indicates better executive abilities.
|
Baseline
|
|
Executive Function as Measured by the Amsterdam Executive Function Inventory (AEFI)
Time Frame: immediately after completing the intervention (about 2 to 4 weeks after baseline)
|
Executive Function as Measured by the 13 item Amsterdam Executive Function Inventory (AEFI) total score ranges from 1 (true) to 3 (not true), higher score indicates better executive abilities.
|
immediately after completing the intervention (about 2 to 4 weeks after baseline)
|
|
Executive Function as Measured by the Amsterdam Executive Function Inventory (AEFI)
Time Frame: 3 months post intervention
|
Executive Function as Measured by the 13 item Amsterdam Executive Function Inventory (AEFI) total score ranges from 1 (true) to 3 (not true), higher score indicates better executive abilities.
|
3 months post intervention
|
|
Executive Function as Measured by the Amsterdam Executive Function Inventory (AEFI)
Time Frame: 6 months post intervention
|
Executive Function as Measured by the 13 item Amsterdam Executive Function Inventory (AEFI) total score ranges from 1 (true) to 3 (not true), higher score indicates better executive abilities.
|
6 months post intervention
|
|
Positive Affect as Measured by Positive and Negative Affect Scale (PANAS-SF)
Time Frame: Baseline
|
PANAS-SF is a 20 item questionnaire, each item is scored from 1(very slightly or not at all)-5(extremely).
Positive affect is measured by 10 items (items 1, 3, 5, 9, 10, 12, 14, 16, 17, and 19) score ranges for 10-50 with higher scores indicating higher levels of positive effect.
The Positive affect score is reported.
|
Baseline
|
|
Positive Affect as Measured by Positive and Negative Affect Scale (PANAS-SF)
Time Frame: immediately after completing the intervention (about 2 to 4 weeks after baseline)
|
PANAS-SF is a 20 item questionnaire, each item is scored from 1(very slightly or not at all)-5(extremely).
Positive affect is measured by 10 items (items 1, 3, 5, 9, 10, 12, 14, 16, 17, and 19) score ranges for 10-50 with higher scores indicating higher levels of positive effect.
The Positive affect score is reported.
|
immediately after completing the intervention (about 2 to 4 weeks after baseline)
|
|
Negative Affect as Measured by Positive and Negative Affect Scale (PANAS-SF)
Time Frame: Baseline
|
PANAS-SF is a 20 item questionnaire, each item is scored from 1(very slightly or not at all)-5(extremely).
Negative affect is measured by 10 items (items 2, 4, 6, 7, 8, 11, 13, 15, 18, and 20) score ranges from 10-50, with lower scores indicating lower levels of negative effect.
The negative affect score is reported.
|
Baseline
|
|
Negative Affect as Measured by Positive and Negative Affect Scale (PANAS-SF)
Time Frame: immediately after completing the intervention (about 2 to 4 weeks after baseline)
|
PANAS-SF is a 20 item questionnaire, each item is scored from 1(very slightly or not at all)-5(extremely).
Negative affect is measured by 10 items (items 2, 4, 6, 7, 8, 11, 13, 15, 18, and 20) score ranges from 10-50, with lower scores indicating lower levels of negative effect.
The negative affect score is reported.
|
immediately after completing the intervention (about 2 to 4 weeks after baseline)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Diane M Santa Maria, DrPH,MSN,RN,PHNA-BC,FSAHM,FAAN, The University of Texas Health Science Center, Houston
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 28, 2022
Primary Completion (Actual)
June 8, 2024
Study Completion (Actual)
June 8, 2024
Study Registration Dates
First Submitted
June 25, 2021
First Submitted That Met QC Criteria
June 25, 2021
First Posted (Actual)
July 6, 2021
Study Record Updates
Last Update Posted (Estimated)
August 28, 2025
Last Update Submitted That Met QC Criteria
August 7, 2025
Last Verified
August 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HSC-SN-20-0466 (Aim 3 Pilot)
- 5R34AT010672-03 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stress, Emotional
-
Lawson Health Research InstituteWestern UniversityCompleted
-
Prof. dr. Filip RaesCompleted
-
Stanford UniversityCompletedStress, EmotionalUnited States
-
Hospital Israelita Albert EinsteinCompletedEmotional StressBrazil
-
University of SussexCompleted
-
Boston Medical CenterCompletedStress, EmotionalUnited States
-
Lawson Health Research InstituteRecruiting
-
Babes-Bolyai UniversityCompletedEmotional StressRomania
-
University of California, San FranciscoCompleted
-
Hospital Israelita Albert EinsteinCompleted
Clinical Trials on tailored MBI (.b)
-
Northwestern UniversityNational Center for Complementary and Integrative Health (NCCIH)CompletedNarcolepsy | Narcolepsy Without Cataplexy | Narcolepsy With CataplexyUnited States
-
Children's Hospital of Eastern OntarioThe Hospital for Sick Children; University of Ottawa; British Columbia Children... and other collaboratorsNot yet recruitingMild Traumatic Brain Injury, Concussion | Concussions | Concussion MildCanada
-
Smart Breast Corp.National Cancer Institute (NCI); University of Texas, Southwestern Medical...Not yet recruitingBreast Neoplasm | Biopsy | Molecular Imaging | Dense Breasts | Breast Cancer DetectionUnited States
-
ARCIM Institute Academic Research in Complementary...Harvard Medical School (HMS and HSDM); Universität TübingenCompletedStress, Psychological
-
Carnegie Mellon UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...Completed
-
Piazza della Vittoria 14 Studio Medico - Ginecologia...CompletedCOVID | Post Traumatic Stress DisorderItaly
-
City, University of LondonCompletedParkinson's DiseaseUnited Kingdom
-
Sunnybrook Health Sciences CentreCompletedDepression | Anxiety | Mood
-
University Hospital, Basel, SwitzerlandETOP IBCSG Partners Foundation; Austrian Breast Cancer Study GroupActive, not recruitingNode-positive Breast CancerUnited States, Latvia, Switzerland, Hungary, Austria, Germany, South Korea, Argentina, Canada, Croatia, Greece, Italy, Lithuania
-
Vanderbilt University Medical CenterTerminatedDepression | Stress | Major Depressive DisorderUnited States